Stellar Biotechnologies, Inc. Intellectual Property Contracts & Agreements

9 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Exclusive License Agreement, dated as of September 21, 2023, by and between Edesa Biotech Research, Inc. and Dr. Saul Yedgar
License Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2023
Third Amendment to Exclusive License Agreement, dated October 26, 2022, by and between the Registrant and Yissum Research Development Company
License Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2022
Exclusive License Agreement, dated as of March 16, 2021, by and between the Edesa Biotech Research, Inc. andDr. Saul Yedgar
License Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2021
License Agreement by and between Edesa Biotech Research, Inc. and NovImmune SA dated April 17, 2020
License Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2020
License and Development Agreement, dated as of August 27, 2017, by and between the Registrant and Pendopharm, a division of Pharmascience Inc
License Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2019
Exclusive License Agreement, dated as of June 15, 2016, by and between the Registrant and Cipher Pharmaceuticals Inc
License Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2019
Second Amendment to Exclusive License Agreement, dated May 7, 2017, by and between the Registrant and Yissum Research Development Company
License Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2019
First Amendment to Exclusive License Agreement, dated April 3, 2017, by and between the Registrant and Yissum Research Development Company
License Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2019
Exclusive License Agreement, dated as of June 29, 2016, by and between the Registrant and Yissum Research Development Company
License Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2019